O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+10.04%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.27B
AUM Growth
+$8.27B
(-0.65%)
Cap. Flow
-$508M
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
34.32%
Holding
163
New
21
Increased
24
Reduced
50
Closed
15
Top Buys
| 1 |
Humana
HUM
|
$108M |
| 2 |
Cigna
CI
|
$87.3M |
| 3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$76.1M |
| 4 |
Molina Healthcare
MOH
|
$72.7M |
| 5 |
Sarepta Therapeutics
SRPT
|
$64.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$125M |
| 2 |
Biogen
BIIB
|
$91M |
| 3 |
Merck
MRK
|
$80.6M |
| 4 |
Select Medical
SEM
|
$74.3M |
| 5 |
Boston Scientific
BSX
|
$65.9M |
Sector Composition
| 1 | Healthcare | 95.17% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
26
DELISTED
Immunomedics Inc
IMMU
| $90.2M | 1.09% | 4,328,573 -616,000 | -12% | -$12.8M |
|
|
BOLD
27
DELISTED
Audentes Therapeutics, Inc
BOLD
| $86.3M | 1.04% | 2,180,000 -435,000 | -17% | -$17.2M |
|
|
NVRO
28
DELISTED
NEVRO CORP.
NVRO
| $77.4M | 0.93% | 1,357,691 +97,600 | +8% | +$5.56M |
|
29
Agilent Technologies
A
$35.7B
| $76.5M | 0.92% | 1,085,100 -800,000 | -42% | -$56.4M |
|
|
PRNB
30
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $76.1M | 0.92% | +2,605,713 | New | +$76.1M |
|
|
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $75.6M | 0.91% | 1,953,500 -52,200 | -3% | -$2.02M |
|
|
AERI
32
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $75.1M | 0.9% | 1,219,830 -664,270 | -35% | -$40.9M |
|
33
Adicet Bio
ACET
$59.9M
| $73.1M | 0.88% | 4,830,387 | – | – |
|
|
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
| $73.1M | 0.88% | 4,806,900 -94,000 | -2% | -$1.43M |
|
|
35
Molina Healthcare
MOH
$9.8B
| $72.7M | 0.88% | +488,781 | New | +$72.7M |
|
36
Dentsply Sirona
XRAY
$2.85B
| $71.3M | 0.86% | 1,889,200 -504,300 | -21% | -$19M |
|
37
Pediatrix Medical
MD
$1.5B
| $68.6M | 0.83% | 1,469,300 +606,700 | +70% | +$28.3M |
|
|
BLUE
38
DELISTED
bluebird bio
BLUE
| $67M | 0.81% | 459,200 -29,000 | -6% | -$4.23M |
|
|
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
| $65.6M | 0.79% | 2,234,570 -96,300 | -4% | -$2.83M |
|
40
Iovance Biotherapeutics
IOVA
$807M
| $62.4M | 0.75% | 5,548,326 | – | – |
|
41
PTC Therapeutics
PTCT
$3.92B
| $59.9M | 0.72% | +1,275,000 | New | +$59.9M |
|
42
Johnson & Johnson
JNJ
$427B
| $57.2M | 0.69% | 414,100 -341,900 | -45% | -$47.2M |
|
|
LOXO
43
DELISTED
Loxo Oncology, Inc
LOXO
| $56.4M | 0.68% | 330,000 -208,000 | -39% | -$35.5M |
|
44
Crinetics Pharmaceuticals
CRNX
$2.92B
| $54.8M | 0.66% | +1,914,282 | New | +$54.8M |
|
45
argenx
ARGX
$43.6B
| $54.5M | 0.66% | 718,800 +119,500 | +20% | +$9.06M |
|
46
Ironwood Pharmaceuticals
IRWD
$214M
| $54.1M | 0.65% | 2,929,250 | – | – |
|
|
VRAY
47
DELISTED
ViewRay, Inc.
VRAY
| $53.7M | 0.65% | 5,736,267 -3,722,300 | -39% | -$34.8M |
|
48
Intuitive Surgical
ISRG
$170B
| $52.9M | 0.64% | 92,200 -18,300 | -17% | -$10.5M |
|
49
Corvus Pharmaceuticals
CRVS
$428M
| $51.2M | 0.62% | 5,967,584 | – | – |
|
50
Exelixis
EXEL
$10.1B
| $49.7M | 0.6% | 2,801,900 +1,120,700 | +67% | +$19.9M |
|